Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT05601141
Recruiting Observational

Clinics and Epidemiology of Pituitary Diseases in Modena Area Population

NCT05601141 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2022-10-24
Last updated
2025-03-14

Condition(s) studied

Pituitary

Study summary

This is an observational, longitudinal, single-center study.

The study is divided in two phases:

* FIRST PHASE (retrospective): registration of all patients affected by pituitary disorders followed at the Unit of Endocrinology of Azienda Ospedaliero-Universitaria of Modena
* SECOND PHASE (prospective): enrollment of all patients affected by pituitary disorders who attend the Unit of Endocrinology of the Azienda Ospedaliero-Universitaria of Modena.

An anonymized database will be created to collect the data of the patients. In particular, the data collected for each patient will include: personal data, data relating to pituitary pathology, symptoms at diagnosis, physical examination, radiological imaging, visual field data, data on surgical intervention, data on histological examination, biohumoral examinations, hormone tests, densitometric data, data on replacement therapies, medical therapies or other pharmacological therapies, data on comorbidities.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * subjects affected by pituitary disorders who attended Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Modena Exclusion Criteria: * subjects under 18 years old

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Modena Modena Modena Recruiting

More Azienda Ospedaliero-Universitaria di Modena trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05601141 on ClinicalTrials.gov ↗ ← All trials in Italy